Related Experiment Videos
Clinical bacteriology of cephazolin
Scottish Medical Journal
|September 1, 1976
Summary
Cephazolin is a potent, broad-spectrum cephalosporin antibiotic effective against many pathogens. Clinical studies show it is a life-saving option for serious infections, rivaling aminoglycosides.
Area of Science:
- Microbiology
- Pharmacology
- Infectious Diseases
Background:
- Cephazolin, a parenteral cephalosporin, was introduced in the UK in 1974.
- Its development traces from early cephalosporin discovery to its 7-aminocephalosporanic acid (7-ACA) nucleus modification.
Observation:
- Cephazolin exhibits bactericidal activity against over 500 pathogens.
- Minimum inhibitory concentrations (MICs) and disc diffusion tests define its antimicrobial spectrum.
- Clinical relevance was assessed by correlating MICs and achievable serum/urine levels with patient outcomes.
Findings:
- Cephazolin demonstrated potent, broad-spectrum, bactericidal activity.
- Comparison with other cephalosporins (cephaloridine, cephalothin, cephalexin, cephradine) revealed significant differences, indicating they are not interchangeable.
- Sensitivity testing is crucial before switching between parenteral and oral forms.
Implications:
- Local policy decisions are needed for optimal cephalosporin selection.
- Cephazolin is a valuable option for severe hospital-acquired infections.
- Cephalosporins, including cephazolin, are recommended as first-line agents, especially in pregnancy and for pulmonary infections.